查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1666181

全球健康监测系统市场 - 2025 至 2033 年

Global Health Monitoring System Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球健康监测系统市场规模达到 512.6 亿美元，预计到 2033 年将达到 994.9 亿美元，2025-2033 年预测期间的复合年增长率为 7.5%。

健康监测系统是一种使用医疗设备、感测器和穿戴式技术监测个人生理参数、生命征象和整体健康状况的技术。它可用于医院环境、家庭护理或远程，实现即时资料收集、及早发现健康异常并及时进行医疗干预。健康监测系统对于慢性病管理、远距患者监测和预防性医疗保健至关重要，可以改善患者的治疗效果并减轻医疗机构的负担。

市场动态：

驱动因素与约束因素

科技进步的崛起

技术进步正在推动全球健康监测系统市场的成长。穿戴式装置、远端病人监控、人工智慧和物联网整合以及智慧感测器正在改变健康资料的收集、分析和利用。这些进步使得即时监测生命征象、早期发现异常以及改善慢性病管理成为可能。基于云端的平台促进了无缝资料储存和共享，增强了医疗保健提供者的决策能力。这提高了健康监测系统的准确性、效率和可近性，推动了全球市场的扩张。

例如，2024 年 8 月，海得拉巴推出了世界上第一个由 Bisam Pharmaceuticals 开发的人工智慧医疗监测应用程式「Quick Vitals」。这款人工智慧应用程式提供即时健康监测、个人化见解和预测分析。它旨在与穿戴式装置配合使用，透过提高诊断准确性和主动护理，有望彻底改变患者护理。

资料隐私和安全问题

由于数位健康解决方案和远端监控设备的日益普及，全球健康监测系统市场面临着资料隐私和安全方面的挑战。网路安全威胁、未经授权的存取和资料外洩对病患的保密和信任构成重大风险。 GDPR 和 HIPAA 等健康资料保护法规的合规性使市场变得复杂，阻碍了资料保护基础设施不够健全的地区广泛采用，从而限制了市场成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 科技进步的崛起
    • 限制
      • 资料隐私和安全问题
    • 机会
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：依产品类型

  • 血糖监测系统
  • 心臟监测设备
  • 多参数监测设备
  • 呼吸监测设备
  • 血流动力学/压力监测设备
  • 体重监测设备
  • 其他的

第 7 章：按指征

  • 糖尿病
  • 心臟病学
  • 呼吸系统
  • 体重管理
  • 其他的

第 8 章：按连结性

  • 无线健康监测设备
  • 有线健康监测设备

第 9 章：按最终用户

  • 医院和诊所
  • 门诊手术中心 (ASC)
  • 家庭护理设置
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Medtronic Plc
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Koninklijke Philips NV
  • Abbott Laboratories
  • GE Healthcare
  • Omron Healthcare, Inc
  • Nihon Kohden Corporation
  • Masimo Corporation
  • Biotronik, Inc
  • Siemens Healthineers AG
  • Boston Scientific Corporation
  • Similar data will be provided for each market player.
  • 欧拉健康
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • 超人
  • 生物福米斯
  • Withings
  • 将为每个市场参与者提供类似的资料。

第 13 章：附录

简介目录
Product Code: MD9191

The Global Health Monitoring System Market reached US$ 51.26 Billion in 2024 and is expected to reach US$ 99.49 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

A Health Monitoring System is a technology that monitors an individual's physiological parameters, vital signs, and overall health status using medical devices, sensors, and wearable technologies. It can be used in hospital settings, home care, or remotely, enabling real-time data collection, early detection of health abnormalities, and timely medical intervention. Health Monitoring Systems are crucial for chronic disease management, remote patient monitoring, and preventive healthcare, enhancing patient outcomes and reducing healthcare facility burden.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

Technological advancements are driving the growth of the Global Health Monitoring System Market. Wearable devices, remote patient monitoring, AI and IoT integration, and smart sensors are transforming health data collection, analysis, and utilization. These advancements enable real-time monitoring of vital signs, early detection of abnormalities, and improved management of chronic conditions. Cloud-based platforms facilitate seamless data storage and sharing, enhancing healthcare providers' decision-making. This has increased the accuracy, efficiency, and accessibility of health monitoring systems, driving market expansion globally.

For instance, in August 2024, Hyderabad has launched the world's first AI-powered healthcare monitoring app, 'Quick Vitals', by Bisam Pharmaceuticals. This AI-powered app offers real-time health monitoring, personalized insights, and predictive analytics. It's designed to work with wearable devices, potentially revolutionizing patient care with improved diagnostic accuracy and proactive care.

Data Privacy and Security Concerns

The Global Health Monitoring System Market faces challenges in data privacy and security due to the increasing adoption of digital health solutions and remote monitoring devices. Cybersecurity threats, unauthorized access, and data breaches pose significant risks to patient confidentiality and trust. Regulatory compliance with health data protection laws like GDPR and HIPAA complicates the market, hindering widespread adoption in regions with less robust data protection infrastructure, limiting market growth.

Segment Analysis

The global health monitoring system market is segmented based on Product Type, Indication, Connectivity, End User and Region.

Product Type:

Blood Glucose Monitoring Systems segment is expected to dominate the Health Monitoring System market share

The blood glucose monitoring systems segment holds a major portion of the health monitoring system market share and is expected to continue to hold a significant portion of the health monitoring system market share during the forecast period.

Blood glucose monitoring systems are crucial in managing diabetes, a condition affecting Billions worldwide. These systems enable real-time monitoring of blood sugar levels, enabling individuals to track fluctuations and adjust lifestyles or medication. Continuous glucose monitoring devices and non-invasive solutions have revolutionized diabetes management, providing accurate readings without frequent finger pricks.

For instance, in November 2024, Beurer India has launched the GL 22 Blood Glucose Monitor, a health monitoring solution designed for the Indian market. The device, manufactured under Beurer's "Make in India" initiative, combines German precision with advanced technology to meet local needs. It offers comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, providing insights into blood glucose trends. These features align with HbA1c levels, a crucial marker for long-term blood sugar control, enabling users and healthcare providers to manage diabetes more effectively.

Furthermore, in June 2024, Prevounce Health has launched its first remote blood glucose monitoring device, the Pylo GL1-LTE. This clinically validated device connects to multiple cellular networks for reliable data transmission throughout the United States. It is compatible with the Prevounce remote care management platform and can integrate with other health software via the Pylo cloud API.

Moreover, technological advancements, like smart glucometers integrated with mobile applications, improve treatment outcomes and encourage preventive care. As diabetes prevalence increases globally, the demand for blood glucose monitoring systems continues to drive market growth.

End User:-

Hospitals & Clinics segment is the fastest-growing segment in Health Monitoring System market share

The hospitals & clinics segment is the fastest-growing segment in the Health Monitoring System market share and is expected to hold the market share over the forecast period.

Hospitals and clinics are a crucial segment in the Global Health Monitoring System Market, relying on advanced devices for accurate patient assessment and timely medical interventions. These systems, including vital sign monitors, cardiac monitors, and remote patient monitoring solutions, help healthcare professionals track patients' health status in real-time, particularly in critical care units and emergency settings. The integration of electronic health records with monitoring devices enhances clinical decision-making and patient care efficiency. With rising patient admissions due to chronic diseases and aging populations, hospitals and clinics remain vital in the market.

Geographical Analysis

North America is expected to hold a significant position in the Health Monitoring System market share

North America holds a substantial position in the Health Monitoring System market and is expected to hold most of the market share due to its advanced healthcare infrastructure, high healthcare expenditure, and the adoption of advanced technologies. The region is home to major health tech companies and is a hub for innovation in digital health solutions like wearable devices and remote monitoring systems. The increasing prevalence of chronic diseases like diabetes and cardiovascular conditions has increased the demand for continuous health monitoring systems. Government initiatives and strong health data privacy regulations ensure system security and reliability.

For instance, in February 2024, Particle Health, a healthcare platform, has launched its Patient Monitoring Solution, offering a 360-degree view of patients' care journeys and interactions with the healthcare system. The solution aims to shift from reactive to proactive care by providing advanced data insights on patient resource utilization. This data aids in more accurate risk management in Value Based Care models, advancing care delivery, and improving patient outcomes.

Europe is growing at the fastest pace in the Health Monitoring System market

Europe holds the fastest pace in the Health Monitoring System market and is expected to hold most of the market share due to its focus on improving healthcare outcomes through innovative technologies. The increasing adoption of telemedicine, remote patient monitoring, and connected devices has improved healthcare delivery, particularly in rural areas. The high prevalence of lifestyle diseases and aging population necessitate efficient health monitoring solutions. Strong government support, eHealth strategies, and robust regulatory frameworks, including GDPR, promote the integration of advanced monitoring systems across public and private healthcare institutions.

For instance, in September 2024, Control Station has launched System Health Monitoring (SHM), a tiered service offering that uses PlantESP Loop Performance Monitoring solution's intelligence for proactive monitoring of deployments. The service enables rapid response to resource issues and provides guidance for achieving world-class control, enrolling dozens of PlantESP licensees and production facilities.

Competitive Landscape

The major global players in the Health Monitoring System market include Medtronic Plc, Koninklijke Philips N.V., Abbott Laboratories, GE Healthcare, Omron Healthcare, Inc, Nihon Kohden Corporation, Masimo Corporation, Biotronik, Inc, Siemens Healthineers AG, Boston Scientific Corporation and among others.

Key Developments

  • In January 2025, AIIMS Raebareli and AIIMS Delhi have launched a real-time health monitoring system at the Maha Kumbh Mela 2025, in collaboration with healthtech firm Lifesigns. The system collects and analyzes vital health data such as ECG, heart rate, respiration, SpO2, blood pressure, and posture, aiming to improve medical response and patient care during the massive gathering.
  • In May 2024, LG Electronics has launched Primefocus Health, a healthcare-delivery platform that uses technologies and therapies for remote patient monitoring and access to new therapies. The platform will allow providers to collect patient data, communicate with patients, track progress, and intervene when needed. It will integrate with electronic health record systems and use AI and machine learning capabilities. This is the first platform launched by LG Electronics North America Innovation Center and LG NOVA.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Health Monitoring System market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Indication
  • 3.3. Snippet by Connectivity
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Data Privacy and Security Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Blood Glucose Monitoring Systems *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cardiac Monitoring Devices
  • 6.4. Multi-Parameter Monitoring Devices
  • 6.5. Respiratory Monitoring Devices
  • 6.6. Hemodynamic/Pressure Monitoring Devices
  • 6.7. Weight Monitoring Devices
  • 6.8. Others

7. By Indication

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 7.1.2. Market Attractiveness Index, By Indication
  • 7.2. Diabetes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Respiratory
  • 7.5. Weight Management
  • 7.6. Others

8. By Connectivity

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 8.1.2. Market Attractiveness Index, By Connectivity
  • 8.2. Wireless Health Monitoring Devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Wired Health Monitoring Devices

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Homecare Settings
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Abbott Laboratories
  • 12.4. GE Healthcare
  • 12.5. Omron Healthcare, Inc
  • 12.6. Nihon Kohden Corporation
  • 12.7. Masimo Corporation
  • 12.8. Biotronik, Inc
  • 12.9. Siemens Healthineers AG
  • 12.10. Boston Scientific Corporation
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Oura Health*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Ultrahuman
  • 12.13. Biofourmis
  • 12.14. Withings
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us